Diagnostics
-
Quest Expands in Cancer Testing With $300M Haystack Oncology Acquisition
Quest Diagnostics is acquiring liquid biopsy company Haystack Oncology. The startup’s technology is used for identifying cancer patients who need adjuvant therapy.
-
StartUPDATES: New Developments from Healthcare Startups
Check out news from BioMEMS Diagnostics, Rx Redefined, Ferrum Health and Avanlee Care.
-
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
-
More Talent and Technology Offer Solutions for Medical Laboratory Staffing Shortages
Process improvement and advanced technology can also help relieve the staffing burden that medical laboratories are facing.
-
Thermo Fisher bets big on blood cancer, immune diagnostics with $2.6B Binding Site buyout
Thermo Fisher Scientific’s acquisition of The Binding Site brings a company that specializes in diagnostic tests for blood cancers and immune system disorders. It’s Thermo Fisher’s biggest acquisition since its 2021 buyout of contract research organization PPD.
-
Report: Cancer deaths are down but pancreatic cancer is growing, racial disparities persist
Targeted drugs and immunotherapies are among the advances that contribute to declines in incidence and deaths from non-small cell lung cancer, according to the Annual Report to the Nation on the Status of Cancer. But the trends are on the rise for some other cancers and racial disparities persist, highlighting the need to better understand these differences.
-
Owkin’s AI solutions for breast and colorectal cancer receive European approval
The breast cancer solution will help determine which patients would benefit from targeted therapies and which patients could avoid chemotherapy. Meanwhile, the colorectal solution will be able to match patients with the most effective treatment sooner.
-
MedCity Influencers, Diagnostics
A Covid-19 reflection: Incorporating what we’ve learned for improved preparedness
Beyond preparedness policies, we need to think forward to policies that rapidly identify the spread of zoonotic disease to prevent or minimize the impact.
-
MedCity Influencers, Diagnostics
Robotics and automation are the future of healthcare
Advanced technologies, such as AI-guided robotics and automation, offer a potential solution to the provider shortage by freeing healthcare professionals from repetitive and time-consuming tasks and allow clinicians to focus on tasks that require a specialized touch.
-
StartUPDATES: New developments from healthcare startups
Check out new developments from BioMEMS Diagnostics, Neuroflow, Druglike, Health Note, and Rhinostics.
-
Payer’s Place: Don Antonucci
The CEO of Providence Health Plan visits the Payer’s Place and addresses the future of payment models.
-
StartUPDATES: New developments from healthcare startups
Check out news from Equiva, Canvas Medical, Particle Health, Fold Health, and Nucleus Genomics.
-
MedCity Influencers, Diagnostics, Health Tech
How vocal biomarkers are becoming a necessary tool for remote patient monitoring
With the information contained in a simple 30-second voice sample, providers can help patients get ahead of future health issues and prescribe or adjust treatment plans as needed.
-
Devices & Diagnostics, Health Services
Two firms team up to facilitate at-home screenings to prevent blindness
MedArrive providers will use Spect’s artificial intelligence-enabled telemedicine platform to screen patients at home for eye diseases such as diabetic retinopathy, glaucoma and age-related macular degeneration.
-
Diagnostic startups: Time is running out to apply to INVEST Pitch Perfect
The point of care diagnostics and testing market has climbed dramatically with the rise of the Covid-19 public health crisis. We’re seeking applications for diagnostics startups who would like to take part in INVEST Pitch Perfect Diagnostics 2.0 track at the conference, scheduled to take place March 28-30 in Chicago.
-
Why Medicare does not cover rapid at-home Covid tests
It turns out that the laws governing traditional Medicare don’t provide for coverage of self-administered diagnostic tests. Medicare patients are left to seek free tests other ways, including through the administration’s new website, covidtests.gov, and at community centers.
-
Sema4 secures a deal to acquire GeneDx, capturing $200M in private investment
The transaction also brought a $200 million investment for Sema4 from life science investors including Pfizer, which can help the combined company’s goal of translating insights from genomics data and analytics into making precision medicine a standard of care.